Oral pre-exposure prophylaxis (PrEP) effectively prevents HIV among men who have sex with men, but its adherence faces significant hindrances. We evaluated the effectiveness of real-time digital intervention in promoting oral PrEP adherence through…
Continue Reading
To evaluate the effectiveness of a digital medication system in improving adherence among patients with serious mental disorders (SMD), we conducted a cluster-randomized controlled trial across 30 communities in Beijing. Participants, aged 18–65 years,…
Continue Reading
Brittany Erana, CEO at Jumo Health
What You Should Know:
– Jumo Health, a global leader in optimizing the patient experience in clinical trials announced the appointment of Brittany Erana as its new Chief Executive Officer.
–…
Continue Reading
Background: Mobile health (mHealth) has been continuously developed to support the HIV care continuum for people living with HIV (PLWH). Considering the practical needs and acceptability of digital health solutions, it is essential to…
Continue Reading
Brooklyn Health, a neuroscience technology company, secured $6.5 million in seed funding. The round was led by HealthX, with participation from Metrodora Ventures, Story Ventures, RiverPark Ventures, Laconia Capital, Everywhere Ventures, Hypothesis Studio and Blue…
Continue Reading
What You Should Know:
– Brooklyn Health, a neuroscience technology company focused on objective measurement of mental health announced it has secured $6.5M in seed funding led by HealthX, with participation from Metrodora Ventures, Story…
Continue Reading
Background: Exercise therapy is strongly recommended as a treatment for chronic non-specific low back pain (CNSLBP). However, therapist guidance exercise therapy requires significant medical resources. Ordinary digital telerehabilitation affects efficacy due to a lack…
Continue Reading
Raj Indupuri, CEO and Co-Founder of eClinical Solutions
For years, the life sciences industry has been trying to address the same R&D challenges: rising costs, patient recruitment and retention, and difficulty maximizing ROI. Drug development is expensive,…
Continue Reading
Israeli startup PhaseV, an AI-enabled clinical development company for life sciences, has secured $50 million in Series A funding in a round co-led by Accel and Insight Partners. Existing investors Viola Ventures, LionBird and EXOR…
Continue Reading
Large-language models (LLMs) show promise for clinical note information extraction, but deployment challenges include high computational costs and privacy concerns. We used synthetic data distillation to fine-tune smaller, open-source LLMs to achieve performance comparable…
Continue Reading
